FBTAX Mutual Fund (Fidelity Advisor Biotechnology Fund Class A) is managed by Fidelity Investments (US) with $772.5M in net assets. FBTAX expense ratio is 0.96%, holding 84 positions across sectors including Health Care, Financials, Unknown. Inception date: 2000-12-27.

FBTAX performance shows a YTD return of 4.36%. The 1-year return is 44.44% and the 5-year return is 8.18%. FBTAX dividend yield stands at 1.15%, paid semi-annually.

FBTAX top holdings include Abbvie Inc (16.6%), Alnylam Pharmace (7.7%), Gilead Sciences Inc (5.5%), Argenx Se Spon Adr Each Rep 1 Ord Shs (4.7%), Fidelity Securities Lending Cash Central Fund (4.3%). View all FBTAX holdings, sector breakdown, or dividend history.

FBTAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBTAX alternatives are available via the screener, along with tax-loss harvesting opportunities.